Decera Clinical Education Infectious Disease Podcast
Podcast image
Treatment of Skin and Soft Tissue Infections
27 mins; July 10, 2023
Answering the Questions on Which HIV PrEP for Which Patient: Latesha Elopre and Jason Farley
26 mins; July 03, 2023
Q&A on Barriers to HIV PrEP: Pharmacist Perspectives
10 mins; June 27, 2023
Older Adults: Overcoming HBV Barriers
39 mins; June 23, 2023
Hepatitis Delta in Focus: Episode 4 of Answering the Questions on Screening, Diagnosis, and Treatment
39 mins; June 22, 2023
Preparing for the Fall: New RSV Vaccine Approvals
12 mins; June 19, 2023
Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment
42 mins; June 19, 2023
Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST
11 mins; June 08, 2023
The Burden of Skin and Soft Tissue Infections: Epidemiology, Clinical Presentation, and Diagnosis
18 mins; June 08, 2023
Choosing Between Initial ART Options: Answering the Questions
46 mins; June 06, 2023
Choosing ART for HIV With HBV and HCV Coinfections: Using HIV-ASSIST
5 mins; May 30, 2023
Integrating New Data on LA ART From CROI 2023: Pharmacist Perspectives
10 mins; May 22, 2023
Christine Katlama and Babafemi Taiwo: Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV
41 mins; May 16, 2023
Preconception ART Selection: Using HIV-ASSIST
8 mins; May 11, 2023
Long-Acting ART: Cabotegravir Plus Rilpivirine
27 mins; May 10, 2023
COVID-19 Update: Independent Conference Coverage of ECCMID 2023
36 mins; May 05, 2023
2023 Audio Recap: Principles of Outpatient COVID-19 Management
74 hours 42 mins; May 03, 2023
Complicated Clinical Infections: Clinical Impact of New Data From ECCMID 2023
30 mins; May 03, 2023
2023 Audio Recap: Practical Case Studies in Outpatient COVID-19 Management
57 mins; May 02, 2023
Q&A: HDV Management Episode 2
40 mins; April 26, 2023
Overcoming HBV Barriers: Focus on Asian American People
52 mins; April 25, 2023
African Immigrant People: Overcoming HBV Barriers
58 mins; April 25, 2023
Individualizing HIV ART: Considerations for Weight Gain
5 mins; April 24, 2023
Rapid ART Initiation: Answering the Questions
49 mins; April 20, 2023
Individualizing HIV ART: Rapid Start
4 mins; April 13, 2023
Perspectives From Asia on Advances in HIV Treatment and Prevention
21 mins; March 27, 2023
RSV in Adults: How It Presents
12 mins; March 22, 2023
RSV in Adults: A Hidden Epidemic
10 mins; March 22, 2023
Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV: José R. Arribas and Melissa Badowski
37 mins; March 21, 2023
Answering the Questions on HIV PrEP Persistence
54 mins; March 16, 2023
Answering Questions on Which HIV PrEP for Which Patient: Carolyn Chu and Samantha Strong
31 mins; March 15, 2023
Hepatitis Delta in Focus: Episode 1 of Answering the Questions on Screening, Diagnosis, and Treatment
22 mins; March 08, 2023
Barriers to HIV PrEP: Addressing Intersectionality
6 mins; March 06, 2023
Long-Acting PrEP: Monitoring for New HIV Infection
3 mins; March 03, 2023
Long-Acting ART: Lenacapavir
5 mins; March 03, 2023
How to Screen for Hepatitis Delta Virus
14 mins; February 23, 2023
Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals
23 mins; February 23, 2023
Ensuring Linkage to Care for Patients Diagnosed With Hepatitis Delta Virus
25 mins; February 23, 2023
Perspectives From Latin America on Advances in HIV PrEP
22 mins; February 17, 2023
Australian Perspectives on Advances in HIV
22 mins; February 17, 2023
Canadian Perspectives on Advances in HIV Treatment and Prevention
19 mins; February 17, 2023
European Perspectives on Advances in HIV Treatment
22 mins; February 17, 2023
Diagnosis and Management of Patients With Long COVID
44 mins; January 31, 2023
The Role of College Campuses in HIV PrEP Uptake
5 mins; January 31, 2023
How Clinic Facilities Can Prepare for Long-Acting Injectable Antiretroviral Therapy
5 mins; January 18, 2023
Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities
23 mins; January 17, 2023
Emerging Insights on Outpatient Management of Acute COVID-19 and Long COVID in Europe
40 mins; January 13, 2023
Administration of LA ART by Community Nurses in France
8 mins; January 05, 2023
PrEP Considerations for Transgender and Nonbinary Individuals
17 mins; January 05, 2023
Optimizing PrEP Selection and Persistence for MSM
19 mins; January 05, 2023
Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?
7 mins; January 04, 2023
What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?
5 mins; January 04, 2023
ART Selection in Treatment-Naive PWH: Weight Gain Considerations
10 mins; December 30, 2022
Should We Be Concerned About Viral Rebound With Antiviral Agents?
4 mins; December 30, 2022
Selecting First-line ART in Treatment-Naive Persons With HIV
23 mins; December 29, 2022
If Treatment Supply Is Limited in Future COVID-19 Viral Peaks, How Do We Ethically Prioritize Patients for Treatment?
7 mins; December 29, 2022
Promoting Meningococcal Vaccine Equity in Adolescent Patients
11 mins; December 28, 2022
Will New COVID-19 Vaccines Affect Risk Stratification?
4 mins; December 27, 2022
The Future of Long-Acting HIV Care: What’s Still Needed
18 mins; December 22, 2022
Improving Access and Acceptance of HIV PrEP for People Who Inject Drugs
4 mins; December 20, 2022
Answering the Questions on Monkeypox in PWH
54 mins; December 19, 2022
Answering the Questions on Considering an ART Switch During Pregnancy
55 mins; December 19, 2022
Expanding Access to Long-Acting ART in Europe
11 mins; December 19, 2022
Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?
12 mins; December 15, 2022
Whom to Screen for Hepatitis Delta Virus
13 mins; December 15, 2022
What Patients Want in HIV Treatment and Prevention: Africa
33 mins; December 14, 2022
Addressing ART Safety and Tolerability in Transgender Individuals
18 mins; December 07, 2022
What Patients Want in HIV Treatment and Prevention: Malaysia
37 mins; December 07, 2022
FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICU
30 mins; December 06, 2022
Newest Viral Hepatitis Data From AASLD 2022
41 mins; December 06, 2022
Practice-Changing Viral Hepatitis Data From AASLD 2022
8 mins; December 06, 2022
Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Audio Recap
38 mins; December 05, 2022
COVID-19 Antiviral Agents and COVID-19 Rebound
46 mins; November 22, 2022
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
37 mins; November 18, 2022
Creative Strategies for Meningococcal Vaccine Uptake
16 mins; November 17, 2022
Barriers and Solutions to Expanding PrEP Uptake: Solutions
10 mins; November 15, 2022
Barriers and Solutions to Expanding PrEP Uptake: People Who Inject Drugs
4 mins; November 15, 2022
Barriers and Solutions to Expanding PrEP Uptake: Cisgender Women
7 mins; November 15, 2022
Barriers and Solutions to Expanding PrEP Uptake: Transgender Women
4 mins; November 15, 2022
Barriers and Solutions to Expanding PrEP Uptake: PrEP Inequities by Race
10 mins; November 14, 2022
Cutting-Edge Concepts in HIV Care: Long-Acting Therapies
19 mins; November 14, 2022
Linkage to Care After HBV Diagnosis in Asian Communities in the US
9 mins; November 14, 2022
Cutting-Edge Concepts in HIV Care: PrEP
13 mins; November 14, 2022
Ending the HIV Epidemic: Persistence on ART
20 mins; November 14, 2022
Treatment Barriers in Asian Communities in the US
12 mins; November 14, 2022
HBV Treatment and Retention in Care Among African Communities in the US
18 mins; November 14, 2022
HBV Screening and Diagnosis Among African Communities in the US
12 mins; November 14, 2022
Practical Case Studies in Outpatient COVID-19 Management
60 hours 53 mins; November 11, 2022
Barriers and Solutions to Expanding PrEP Uptake: Adolescents
7 mins; November 07, 2022
ART Safety Considerations in Aging Patients With HIV
18 mins; November 02, 2022
If RSV Vaccines Are Approved for Older Adults, What’s Next?
13 mins; November 02, 2022
What Patients Want in HIV Treatment and Prevention: United Kingdom
44 mins; November 02, 2022
What Patients Want in HIV Treatment and Prevention: United States
38 mins; November 01, 2022
Addressing Barriers to PrEP Uptake Among Black Cisgender Women
5 mins; October 31, 2022
Addressing Barriers to PrEP Uptake Among Black MSM
6 mins; October 27, 2022
London Perspective: Comorbidity and Adherence Considerations in Older Patients With HBV
10 mins; October 27, 2022
Principles of Outpatient COVID-19 Management
61 hours 9 mins; October 21, 2022
Switching ART in a Virologically Suppressed Person With Suspected Underlying Resistance
7 mins; October 20, 2022
Answering the Questions on Switching ART With Virologic Suppression
57 mins; October 19, 2022
All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance
78 hours 30 mins; October 18, 2022